Tim Wilson
Chief Executive Officer at Epsilogen Ltd.
Profile
Tim Wilson is currently the Chief Executive Officer & Director at Epsilogen Ltd.
He previously worked as a Managing Director at UBS Securities LLC, Senior Managing Director at Bear Stearns International Ltd., and Managing Director at Hambrecht & Quist LLC.
Prior to that, he worked as a Research Analyst at Pacific Growth Equities, Inc. from 2006 to 2009.
Dr. Wilson received his undergraduate degree from Imperial College London and his doctorate from the University of Cambridge.
Tim Wilson active positions
Companies | Position | Start |
---|---|---|
Epsilogen Ltd.
Epsilogen Ltd. Pharmaceuticals: MajorHealth Technology Epsilogen Ltd. engages in the development of immunoglobulin E (IgE) antibodies to treat cancer. The firm offers IGEG platform technology based on combining the power of IgE and Immunoglobulin G (IgG) antibody molecules. The company was founded by Sophia Karagiannis and James Spicer and is headquartered in London, United Kingdom. | Chief Executive Officer | 31/03/2017 |
Former positions of Tim Wilson
Companies | Position | End |
---|---|---|
Pacific Growth Equities, Inc.
Pacific Growth Equities, Inc. Investment Banks/BrokersFinance Pacific Growth Equities, Inc. is a research-driven investment bank located headquartered in San Francisco with an additional office in Boston. The firm specializes in technology-based emerging growth companies. They offer investment banking and brokerage services including public equity offerings, private equity offerings and mergers and acquisitions. Pacific Growth focuses on the life sciences, technology, healthcare and consumer growth companies. | Analyst-Equity | 27/02/2009 |
UBS Securities LLC
UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Analyst-Equity | - |
Hambrecht & Quist LLC | Analyst-Equity | - |
Bear Stearns International Ltd. | Analyst-Equity | - |
Training of Tim Wilson
University of Cambridge | Doctorate Degree |
Imperial College London | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Pacific Growth Equities, Inc.
Pacific Growth Equities, Inc. Investment Banks/BrokersFinance Pacific Growth Equities, Inc. is a research-driven investment bank located headquartered in San Francisco with an additional office in Boston. The firm specializes in technology-based emerging growth companies. They offer investment banking and brokerage services including public equity offerings, private equity offerings and mergers and acquisitions. Pacific Growth focuses on the life sciences, technology, healthcare and consumer growth companies. | Finance |
Bear Stearns International Ltd. | Finance |
Hambrecht & Quist LLC | Finance |
UBS Securities LLC
UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Finance |
Epsilogen Ltd.
Epsilogen Ltd. Pharmaceuticals: MajorHealth Technology Epsilogen Ltd. engages in the development of immunoglobulin E (IgE) antibodies to treat cancer. The firm offers IGEG platform technology based on combining the power of IgE and Immunoglobulin G (IgG) antibody molecules. The company was founded by Sophia Karagiannis and James Spicer and is headquartered in London, United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Tim Wilson